In a preliminary analysis, the Cologuard colorectal cancer screening test met or exceeded all primary and secondary endpoints of its recently completed DeeP-C pivotal clinical trial.
http://www.formkit.com/news/DailyDetail.cfm?chosen=67304
http://www.formkit.com/news/DailyDetail.cfm?chosen=67304
No comments:
Post a Comment